Healthcare -
Biotechnology - NASDAQ - US
$ 0.8696
-0.046 %
$ 47.4 M
Market Cap
10.87
P/E
SPRO - COST OF REVENUE
Cost of Revenue SPRO - Spero Therapeutics, Inc.
367 K
LAST VALUE
-42.68%
2 YEAR CAGR
-59.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR